Vistin Pharma — Proxy Solicitation & Information Statement 2026

Apr 28, 2026

Proposal from the Election Committee in Vistin Pharma ASA for the Annual General Meeting to be held in May 2026

The following constitute the Election Committee of Vistin Pharma ASA:

• Eivind Devold (Chairman)
• Nils Erling Ødegaard

The Election Committee has evaluated the work of the Board of Directors and received input from shareholders about the composition of the Board.

Election of Board members

The two-year election period for the following Board members expires at the AGM in 2026, and therefore all members are up for election:

• Øyvin A. Brøymer
• Bettina Banoun
• Kari Krogstad
• Espen Marcussen

The Election Committee proposes no changes on the Board, and consequently that the above listed Board members are all re-elected for a new two-year period until AGM 2028.

If the shareholders approve the proposal from the Election Committee, the Board will consist of the following shareholder elected members:

• Øyvin A. Brøymer
• Bettina Banoun
• Kari Krogstad
• Espen Marcussen

Observer on the board

Kjell-Erik Nordby has had a role as an observer to the board for a period of 2 years, expiring at the annual general meeting in 2026. The nomination committee proposes that this role is not extended.

Election of members for the Election Committee

The two-year election period for the current members of the Election Committee expires at the AGM in 2027.

The Election Committee consequently consists of the following members until AGM 2027:

• Eivind Devold (Chairman)
• Nils Erling Ødegaard